Description
Global Cell-Based Assay Market Industry Overview
The global cell-based assay market is expected to reach $38.23 billion in 2032 from $17.20 billion in 2022, at a CAGR of 8.44% during the forecast period 2023-2032.
Market Lifecycle Stage
The global cell-based assay market is anticipated to witness growth during the forecast year 2023-2032, largely fuelled by the promise of a novel breakthrough in the cell-based assay market, which is no longer restricted to drug discovery. The foremost advantage of utilizing cell-based assays is apparent: unlike basic biochemical assays, they provide a more comprehensive representation of biological systems as they encompass not just an isolated receptor or enzyme but all the organelles of a cell functioning as a single entity.
Impact
The impact analysis for the factors that significantly affect the market, namely, drivers, restraints, and opportunities, has been evaluated on a short-term and long-term basis. The short-term assessment considers the period between 2022 and 2026, and the long-term assessment considers the period between 2027 and 2032.
Key developments and strategies that have been undertaken by some of the key players in this market have been accounted for evaluation of the impact analysis. Further, these key developments have been assessed to understand the future scope of integrating advancing technologies to enable superior outcomes.
Impact of COVID-19
The cell-based assay market has also been impacted by the pandemic. As per World Health Organization (WHO), COVID-19 has affected millions of people, resulting in a considerable number of deaths. In response, companies have intensified their research and development efforts to create vaccines and treatments for the SARS-CoV-2 virus. This research is considered critical and has remained unaffected, with operations and output continuing as before. As a result of the increase in research activities, the availability of research funding and demand for cell-based test products are expected to expand.
Companies in the industry are adapting their long-and short-term growth strategies to capitalize on opportunities in the research market by introducing innovative products to combat the pandemic. The need for COVID-19 research has created a broad scope for cell-based tests in viral infection research, vaccine development, and drug discovery.
Various COVID-19 vaccines and antiviral medications have been authorized or are under development, and patients are being treated symptomatically. The functional efficiency of the antibodies produced to neutralize the virus is assessed using cell-based assays for both vaccines and treatments. In order to reduce time and increase throughput, cell-based assays are utilized. As a result, the demand for cell-based assays to provide early indications of symptoms in patients has increased. Consequently, the overall
Impact of COVID-19
on the cell-based assay market is predicted to be positive.
Market Segmentation:
Global Cell-Based Assay Market
Segmentation 1: by Product
• Consumables
• Instruments and Software
• Services
Based on product type, the global cell-based assay market is segmented into consumables, instruments and software, and services.
Segmentation 2: by Region
• North America
• Europe
• Asia-Pacific
• Rest-of-the-World
In 2022, the North America region dominated the global cell-based assay market, and it is expected to hold its dominance throughout the forecast period 2023-2032.
Segmentation 3: by Application
• Drug Screening
• Basic Research
• Predictive Toxicology
• Other Applications (Other Industries, Cell and Gene therapy, among others)
As of 2022, the cell-based assay market (by application) was dominated by drug screening applications, holding a 41.27% market share.
Segmentation 4: by Technology
• Flow Cytometry
• Automated Handling
• High Throughput Screening
• High Content Screening
• Other Technologies (Label-Free Detection, Image Cytometry, among others)
As of 2022, the global cell-based assay market (by technology) was dominated by flow cytometry, holding a 34.11% market share.
Segmentation 5: by End User
• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutes
• Other End Users (Government Organizations)
As of 2022, the global cell-based assay market (by end user) was dominated by the pharmaceutical and biopharmaceutical companies’ segment, holding a 51.36% market share.
Segmentation 6: by Company
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Corning Incorporated
• Lonza Group AG
• Agilent Technologies, Inc.
• Promega Corporation
• PerkinElmer, Inc.
• Eurofins DiscoverX Products
• Cell Signaling Technology, Inc.
• Charles River Laboratories International, Inc.
• Laboratory Corporation of America Holdings
Based on company, the global cell-based assay market is dominated by Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, among others.
Recent Developments in the Global Cell-Based Assay Market
• In April 2022, Lonza Group AG announced an enhancement to its automated cell therapy manufacturing system called the Cocoon Platform. The latest addition, known as magnetic selection, broadens the platform’s capabilities by enabling cell binding, separation, and bead removal (if needed), all conducted through the Cocoon cassette.
• In April 2020, Bio-Rad Laboratories, Inc. completed the acquisition of Celsee, Inc., a company that provides instruments and consumables that enable the isolation, detection, and analysis of individual cells.
• In July 2021, PerkinElmer, Inc. announced that it had reached a definitive agreement to acquire BioLegend, a manufacturer of high-quality antibodies and reagents used in biomedical research, for $5.25 billion.
• In April 2021, Lonza Group AG and Junshi Biosciences announced an expansion of their collaboration aimed at developing and manufacturing biologics. Lonza Group AG would utilize its worldwide network and local operational expertise to help Junshi Biosciences speed up the development of drugs in its pipeline and increase their adoption in the global market. According to the agreement, Lonza Group AG would provide comprehensive assistance, including cell line creation and development, the supply of cell culture media and reagents, process development, and GMP manufacturing.
• In July 2021, Lonza Group AG and CN Bio established a distribution agreement that involves Lonza Group AG providing hepatic cells to CN Bio for prequalification, which would be utilized in their PhysioMimix single-and multi-organ MPS technology. This collaboration aims to revolutionize the generation of preclinical data that is relevant to humans. By using prequalified cells, customers can avoid the need to experiment with multiple cell types, thereby saving time and ensuring the discovery of cells that will grow and function effectively in 3D culture.
Demand – Drivers and Limitations
The following are the demand drivers for the global cell-based assay market:
• Increase in Demand for Cell-Based Assay in Drug Discovery and Development
• Rise in Life Sciences Research Investments
• Technological Advancements
The market is expected to face some limitations due to the following challenges:
• High Cost
• Lack of Standardization
How can this report add value to an organization?
Workflow/Innovation Strategy: The global cell-based assay market is segmented (by product) into three categories, i.e., consumables, instruments and software, and services. The consumables segment is further classified as reagents, assay kits, microplates, cell lines, probes and labels, and other consumables.
Reagents accounted for 29.43% of the share in the global cell-based assay market from 2022 to 2032.
Growth/Marketing Strategy: The global cell-based assay market is anticipated to witness growth during the forecast year 2023-2032. The advent of CRISPR/Cas9 technology has completely transformed gene studies and their functions by offering highly precise and user-friendly genome editing capabilities. CRISPR significantly streamlines the development of more intricate disease-related cell-based assays, enabling researchers to tackle complex questions and study heterogeneous diseases with more relevant and sophisticated assays.
Competitive Strategy: Key players in the global cell-based assay market have been analyzed and profiled in the study, including manufacturers involved in new product development, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global cell-based assay market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Table of Contents
1 Definition
1.1 Inclusion and Exclusion Criteria
2 Research Scope
2.1 Target Audience
2.2 Key Questions Answered in the Report:
3 Research Methodology
3.1 Global Cell-Based Assay Market: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
3.5 Criteria for Company Profiling
4 Markets Overview
4.1 Market Introduction
4.1.1 Types of Cell-Based Assays
4.2 Current and Future State of Cell-Based Assays in Industries
4.3 Emerging Technologies and Applications in the Global Cell-Based Assay Market
4.4 Current Market Size and Growth Potential, $Billion, 2022-2032
4.5 COVID-19 Impact on Global Cell-Based Assay Market
4.5.1 Impact on Cell-Based Assay Companies
5 Industry Insights
5.1 Overview
5.2 Legal Requirements and Frameworks in the U.S.
5.3 Legal Requirements and Frameworks in Europe
5.4 Legal Requirements and Frameworks in Asia-Pacific
5.4.1 Legal Requirements and Frameworks in Japan
6 Market Dynamics
6.1 Overview
6.2 Impact Analysis
6.2.1 Market Drivers
6.2.1.1 Increase in Demand for Cell-Based Assay in Drug Discovery and Development
6.2.1.2 Rise in Life Sciences Research Investments
6.2.1.3 Technological Advancements
6.2.2 Market Restraints
6.2.2.1 High Cost
6.2.2.2 Lack of Standardization
6.2.3 Market Opportunities
6.2.3.1 Increased Focus on Regenerative Medicine
6.2.3.2 Emergence of Novel Gene Editing Technologies
7 Competitive Landscape
7.1 Competitive Landscape Overview
7.1.1 Key Developments
7.1.2 Product Launch and Expansion Activities
7.1.3 Merger and Acquisition Activities
7.1.4 Synergistic Activities
7.1.5 License and Agreement Activities
7.2 Market Share Analysis (2022)
7.3 Growth-Share Analysis (2021-2022)
7.3.1 Growth-Share Analysis (by Company)
8 Global Cell-Based Assay Market (by Product),$Billion, 2022-2032
8.1 Overview
8.2 Consumables
8.2.1 Reagents
8.2.2 Assay Kits
8.2.3 Microplates
8.2.4 Cell Lines
8.2.5 Probes and Labels
8.2.6 Other Consumables
8.3 Instruments and Software
8.4 Services
9 Global Cell-Based Assay Market (by Application), $Billion, 2022-2032
9.1 Overview
9.1.1 Drug Screening
9.1.2 Basic Research
9.1.3 Predictive Toxicology
9.1.4 Other Applications (Other Industries, Cell and Gene Therapy, and Others)
10 Global Cell-Based Assay Market (by End User), $Billion, 2022-2032
10.1 Overview
10.2 Pharmaceutical and Biopharmaceutical Companies
10.3 Contract Research Organizations (CROs)
10.4 Academic and Research Institutes
10.5 Other End Users (Government Organizations)
11 Global Cell-Based Assay Market (by Technology), $Billion, 2022-2032
11.1 Overview
11.2 Flow Cytometry
11.3 Automated Handling
11.4 High-Throughput Screening
11.5 High-Content Screening
11.6 Other Technologies (Label-Free Detection, Image Cytometry, and Others)
12 Global Cell-Based Assay Market (by Region), $Billion, 2022-2032
12.1 Overview
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.3 Europe
12.3.1 Germany
12.3.2 U.K.
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 Rest-of-Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Australia
12.4.6 Rest-of-Asia-Pacific
12.5 Rest-of-the-World
13 Company Profiles
13.1 Overview
13.1.1 Becton, Dickinson and Company
13.1.1.1 Company Overview
13.1.1.2 Role of Becton, Dickinson and Company in the Global Cell-Based Assay Market
13.1.1.3 Major Product: Key Specifications
13.1.1.4 Customers and Competitions
13.1.1.4.1 Key Customers
13.1.1.4.2 Key Competitors
13.1.1.5 Analyst Perspective
13.1.2 Bio-Rad Laboratories, Inc.
13.1.2.1 Company Overview
13.1.2.2 Role of Bio-Rad Laboratories, Inc. in the Global Cell-Based Assay Market
13.1.2.3 Major Product: Key Specifications
13.1.2.4 Customers and Competitions
13.1.2.4.1 Key Customers
13.1.2.4.2 Key Competitors
13.1.2.5 Analyst Perspective
13.1.3 Danaher Corporation
13.1.3.1 Company Overview
13.1.3.2 Role of Danaher Corporation in the Global Cell-Based Assay Market
13.1.3.3 Major Product: Key Specifications
13.1.3.4 Customers and Competitions
13.1.3.4.1 Key Customers
13.1.3.4.2 Key Competitors
13.1.3.5 Analyst Perspective
13.1.4 Merck KGaA
13.1.4.1 Company Overview
13.1.4.2 Role of Merck KGaA in the Global Cell-Based Assay Market
13.1.4.3 Major Product: Key Specifications
13.1.4.4 Key Competitors
13.1.4.5 Analyst Perspective
13.1.5 Thermo Fisher Scientific, Inc.
13.1.5.1 Company Overview
13.1.5.2 Role of Thermo Fisher Scientific, Inc. in the Global Cell-Based Assay Market
13.1.5.3 Major Product: Key Specifications
13.1.5.4 Key Competitors
13.1.5.5 Analyst Perspective
13.1.6 Corning Incorporated
13.1.6.1 Company Overview
13.1.6.2 Role of Corning Incorporated in the Global Cell-Based Assay Market
13.1.6.3 Major Product: Key Specifications
13.1.6.4 Key Competitors
13.1.6.5 Analyst Perspective
13.1.7 Lonza Group AG
13.1.7.1 Company Overview
13.1.7.2 Role of Lonza Group AG in the Global Cell-Based Assay Market
13.1.7.3 Major Product: Key Specifications
13.1.7.4 Key Competitors
13.1.7.5 Analyst Perspective
13.1.8 Agilent Technologies, Inc.
13.1.8.1 Company Overview
13.1.8.2 Role of Agilent Technologies, Inc. in the Global Cell-Based Assay Market
13.1.8.3 Major Product: Key Specifications
13.1.8.4 Customers and Competitions
13.1.8.4.1 Key Customers
13.1.8.4.2 Key Competitors
13.1.8.5 Analyst Perspective
13.1.9 Promega Corporation
13.1.9.1 Company Overview
13.1.9.2 Role of Promega Corporation in the Global Cell-Based Assay Market
13.1.9.3 Major Product: Key Specifications
13.1.9.4 Customers and Competitions
13.1.9.4.1 Key Customers
13.1.9.4.2 Key Competitors
13.1.9.5 Analyst Perspective
13.1.10 PerkinElmer, Inc.
13.1.10.1 Company Overview
13.1.10.2 Role of PerkinElmer Inc. in the Global Cell-Based Assay Market
13.1.10.3 Major Product: Key Specifications
13.1.10.4 Key Competitors
13.1.10.5 Analyst Perspective
13.1.11 Eurofins DiscoverX Products
13.1.11.1 Company Overview
13.1.11.2 Role of Eurofins DiscoverX Products in the Global Cell-Based Assay Market
13.1.11.3 Major Product: Key Specifications
13.1.11.4 Key Competitors
13.1.11.5 Analyst Perspective
13.1.12 Cell Signaling Technology, Inc.
13.1.12.1 Company Overview
13.1.12.2 Role of Cell Signaling Technology, Inc. in the Global Cell-Based Assay Market
13.1.12.3 Major Product: Key Specifications
13.1.12.4 Key Competitors
13.1.12.5 Analyst Perspective
13.1.13 Charles River Laboratories International, Inc.
13.1.13.1 Company Overview
13.1.13.2 Role of Charles River Laboratories International, Inc. in the Global Cell-Based Assay Market
13.1.13.3 Major Product: Key Specifications
13.1.13.4 Key Competitors
13.1.13.5 Analyst Perspective
13.1.14 Laboratory Corporation of America Holdings
13.1.14.1 Company Overview
13.1.14.2 Role of Laboratory Corporation of America Holdings in Global Cell-Based Assay Market
13.1.14.3 Major Product: Key Specifications
13.1.14.4 Key Competitors
13.1.14.5 Analyst’s Perspective
List of Figures
Figure 1: Impact Analysis of Drivers, Challenges, and Opportunities on the Global Cell-Based Assay Market
Figure 2: Global Cell-Based Assay Market (by Product), $Billion, 2022-2032
Figure 3: Global Cell-Based Assay Market (by End User), $Billion, 2022 and 2032
Figure 4: Global Cell-Based Assay Market (by Region), 2022
Figure 5: Global Cell-Based Assay Market Regional Segmentation
Figure 6: Global Cell-based Assay Market Methodology
Figure 7: Primary Research Methodology
Figure 8: Top-Down Approach (Segment-Wise Analysis)
Figure 9: Bottom-Up Approach (Segment-Wise Analysis)
Figure 10: Cellular Processes Utilized to Investigate the Impacts in Cell-Based Assays
Figure 11: Emerging Technologies in the Global Cell-Based Assay Market
Figure 12: Global Cell-Based Assay Market, $Billion, 2022-2032
Figure 13: Impact of COVID-19 on Cell-Based Assay Companies
Figure 14: Global Cell-Based Assay Market - Market Dynamics
Figure 15: Total U.S. Life Sciences Venture Capital Funding, $Billion, 2016-2021
Figure 16: Uses of Cell-based Assays in Regenerative Medicine
Figure 17: Share of Key Developments and Strategies, January 2020 to March 2023
Figure 18: Share of Product Launch and Expansion Activities (by Company), January 2020 to March 2023
Figure 19: Share of Merger and Acquisition Activities (by Company), January 2020 to March 2023
Figure 20: Share of Synergistic Activities (by Company), January 2020 to March 2023
Figure 21: Market Share Analysis for Global Cell-Based Assay Market, 2022
Figure 22: Growth-Share Analysis for Global Cell-Based Assay Market (by Company), 2021-2022
Figure 23: Global Cell-Based Assay Market (by Product), $Billion, 2022-2032
Figure 24: Global Cell-Based Assay Market (Consumables), $Billion, 2022-2032
Figure 25: Global Cell-Based Assay Market (Reagents), $Billion, 2022-2032
Figure 26: Global Cell-Based Assay Market (Assay Kits), $Billion, 2022-2032
Figure 27: Global Cell-Based Assay Market (Microplates), $Billion, 2022-2032
Figure 28: Global Cell-Based Assay Market (Cell Lines), $Billion, 2022-2032
Figure 29: Global Cell-Based Assay Market (Probes and Labels), $Billion, 2022-2032
Figure 30: Global Cell-Based Assay Market (Other Consumables), $Billion, 2022-2032
Figure 31: Global Cell-Based Assay Market (Instruments and Software), $Billion, 2022-2032
Figure 32: Global Cell-Based Assay Market (Services), $Billion, 2022-2032
Figure 33: Global Cell-Based Assay Market (by Application)
Figure 34: Global Cell-Based Assay Market (by Application), $Billion, 2022 and 2032
Figure 35: Global Cell-Based Assay Market (Drug Screening), $Billion, 2022-2032
Figure 36: Global Cell-Based Assay Market (Basic Research), $Billion, 2022-2032
Figure 37: Global Cell-Based Assay Market (Predictive Toxicology), $Billion, 2022-2032
Figure 38: Global Cell-Based Assay Market (Other Applications), $Billion, 2022-2032
Figure 39: Global Cell-Based Assay Market (by End User)
Figure 40: Global Cell-Based Assay Market (by End User), $Billion, 2022 and 2032
Figure 41: Global Cell-Based Assay Market (Pharmaceutical and Biopharmaceutical Companies), $Billion, 2022-2032
Figure 42: Global Cell-Based Assay Market (Contract Research Organizations (CROs)), $Billion, 2022-2032
Figure 43: Global Cell-Based Assay Market (Academic and Research Institutes), $Billion, 2022-2032
Figure 44: Global Cell-Based Assay Market (Other End Users (Government Organizations), $Billion, 2022-2032
Figure 45: Global Cell-Based Assay Market (by Technology)
Figure 46: Global Cell-Based Assay Market (by Technology), $Billion, 2022 and 2032
Figure 47: Global Cell-Based Assay Market (Flow Cytometry), $Billion, 2022-2032
Figure 48: Global Cell-Based Assay Market (Automated Handling), $Billion, 2022-2032
Figure 49: Global Cell-Based Assay Market (High-Throughput Screening), $Billion, 2022-2032
Figure 50: Global Cell-Based Assay Market (High-Content Screening), $Billion, 2022-2032
Figure 51: Global Cell-Based Assay Market (Other Technologies), $Billion, 2022-2032
Figure 52: Global Cell-Based Assay Market Snapshot (by Region)
Figure 53: Global Cell-Based Assay Market (by Region), $Billion, 2022-2032
Figure 54: North America Cell-Based Assay Market, $Billion, 2022-2032
Figure 55: North America: Market Dynamics
Figure 56: North America Cell-Based Assay Market (by Country), $Billion, 2022-2032
Figure 57: U.S. Cell-Based Assay Market, $Billion, 2022-2032
Figure 58: Canada Cell-Based Assay Market, $Billion, 2022-2032
Figure 59: Europe Cell-Based Assay Market, $Billion, 2022-2032
Figure 60: Europe: Market Dynamics
Figure 61: Europe Cell-Based Assay Market (by Country), $Billion, 2022-2032
Figure 62: Germany Cell-Based Assay Market, $Billion, 2022-2032
Figure 63: U.K. Cell-Based Assay Market, $Billion, 2022-2032
Figure 64: France Cell-Based Assay Market, $Billion, 2022-2032
Figure 65: Italy Cell-Based Assay Market, $Billion, 2022-2032
Figure 66: Spain Cell-Based Assay Market, $Billion, 2022-2032
Figure 67: Rest-of-Europe Cell-Based Assay Market, $Billion, 2022-2032
Figure 68: Asia-Pacific Cell-Based Assay Market, $Billion, 2022-2032
Figure 69: Asia-Pacific: Market Dynamics
Figure 70: Asia-Pacific Cell-Based Assay Market (by Country), $Billion, 2022-2032
Figure 71: China Cell-Based Assay Market, $Billion, 2022-2032
Figure 72: Japan Cell-Based Assay Market, $Billion, 2022-2032
Figure 73: India Cell-Based Assay Market, $Billion, 2022-2032
Figure 74: South Korea Cell-Based Assay Market, $Billion, 2022-2032
Figure 75: Australia Cell-Based Assay Market, $Billion, 2022-2032
Figure 76: Rest-of-Asia-Pacific Cell-Based Assay Market, $Billion, 2022-2032
Figure 77: Rest-of-the-World Cell-Based Assay Market, $Billion, 2022-2032
Figure 78: Total Number of Companies Profiled
Figure 79: Becton, Dickinson and Company: Product Portfolio
Figure 80: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 81: Danaher Corporation: Product Portfolio
Figure 82: Merck KGaA: Product Portfolio
Figure 83: Thermo Fisher Scientific, Inc.: Product Portfolio
Figure 84: Corning Incorporated: Product Portfolio
Figure 85: Lonza Group AG: Product Portfolio
Figure 86: Agilent Technologies, Inc.: Product Portfolio
Figure 87: Promega Corporation: Product Portfolio
Figure 88: PerkinElmer Inc.: Product Portfolio
Figure 89: Eurofins DiscoverX Products: Product Portfolio
Figure 90: Cell Signaling Technology, Inc.: Product Portfolio
Figure 91: Charles River Laboratories International, Inc.: Product Portfolio
Figure 92: Laboratory Corporation of America Holdings.: Product Portfolio
List of Tables
Table 1: Current and Future State of Cell-Based Assay in Industries
Table 2: Utilizing the Potential of Cell-Based Assays: Novel Instruments and Methodologies in 2020-2021
Companies Mentioned
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation
Merck KGaA
Thermo Fisher Scientific, Inc.
Corning Incorporated
Lonza Group AG
Agilent Technologies, Inc.
Promega Corporation
PerkinElmer, Inc.
Eurofins DiscoverX Products
Cell Signaling Technology, Inc.
Charles River Laboratories International, Inc.
Laboratory Corporation of America Holdings
Reviews
There are no reviews yet.